Discover trends, market shifts, and competitive outlooks for the diverticulitis disease industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Diverticulitis Disease Market From 2025 To 2029?

In recent times, the market size for diverticulitis disease has seen accelerated growth. The market is projected to expand from $1.85 billion in 2024 to $2.04 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. Factors such as an aging population, obesity, changing dietary habits, and improvements in medical imaging technologies are attributed to the growth observed in the historic period.

In the coming years, the market size of diverticulitis disease is likely to undergo substantial growth, reaching a value of $2.92 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth in the projection period include procedures like colonoscopy and endoscopy, heightened awareness, minimally invasive procedures, and personal medicine approaches. Key trends in the estimated period encompass preventive strategies, upgraded diagnostic instruments, cooperative care schemes, and alterations in healthcare policies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Diverticulitis Disease Market?

The increasing incidence of smoking addiction is predicted to spur the growth of the diverticulitis disease market in the future. Aggressive advertising, societal acceptance, stress, and nicotine’s addictive properties are driving smoking addiction rates higher. With the accessibility of e-cigarettes and vapes, alongside social impacts and peer pressure, particularly in younger generations, smoking rates are seeing a rapid increase. Increased smoking tends to amplify the growth of diverticulitis treatments as it elevates the risk of developing serious complications related to diverticular disease as it diminishes blood flow to the colon. Therefore, causing greater demand for diagnostic and therapeutic alternatives. For instance, in July 2022, as per Statistics Canada, a government agency based in Canada, cigarette production witnessed a 5.8% growth compared to June 2021. There was also a 1.3% increase in the total number of cigarettes sold from May 2022, tallying 1.4 billion in June 2022. Hence, the increasing addiction towards smoking is forecasted to stimulate the diverticulitis disease market’s growth. An increase in diabetes prevalence is foreseen as a key growth factor for the diverticulitis disease market. Factors such as unhealthy diet patterns laden with processed foods, inactive lifestyles, increased obesity numbers, genetic predispositions, and an aging demographic mainly drive the rise of diabetes. This illness intensifies the possibility of complications like weakened blood vessels, making the colon more prone to infection and inflammation, thus raising the need for treatments. For instance, The National Health Service (NHS England), a publicly funded healthcare system in the UK, reported in June 2024 that in 2023, 3,615,330 individuals were identified with pre-diabetes, an increase of 18% from 3,065,825 in 2022. Cases among those below 40 also shot up by nearly 25%, rising from 173,166 in 2022 to 216,440 in 2023. Thus, the rising prevalence of diabetes is contributing to the growth of the diverticulitis disease market.

Which Segments in the Diverticulitis Disease Offer the Most Growth?

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids

4) By End-User: Specialty Centers, Hospitals, Research centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp

What Are the Fastest-Growing Geographies in the Diverticulitis Disease Market?

North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Current Market Growth and Trends in the Diverticulitis Disease Industry?

In an effort to maintain their market prominence, leading players in the diverticulitis disease market are focused on innovating and securing approval for new drugs. This process not only enhances the efficiency of diverticulitis treatment, but it also minimizes the possibility of complications, thereby benefitting overall patient health. For instance, in April 2023, Seres’ microbiota medication for recurring gut infections received approval from the US-based federal agency, the United States Food and Drug Administration. It is intended to treat recurrent gut infections and reduce the likelihood of repeated Clostridioides difficile (C. diff.) infections in adults over the age of 18. The approval of Vowst was contingent upon a clinical trial featuring 346 patients with recurring CDI. The study found that the instances of infection recurrence were significantly lower in patients who received Vowst compared to those given a placebo. The orally administered drug centers on Firmicutes spores-containing microbiota, which are imperative for a healthy microbiome resistant to C. diff. colonization.

View the full report here:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

What Are the Key Elements That Define the Diverticulitis Disease Market?

Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model